How Onco PGx Reduces Chemotherapy Side Effects in Colorectal Cancer
Colorectal cancer (CRC) remains a significant global health challenge, necessitating continuous advancements in treatment strategies. Chemotherapy, a cornerstone of CRC management, often presents a trade-off between efficacy and toxicity. Inter-individual variability in response to chemotherapy agents highlights the need for personalized approaches. Onco PGx addresses this challenge by analyzing genetic variations that influence how patients […]
How Onco PGx Reduces Chemotherapy Side Effects in Colorectal Cancer Read More »










